PDF) C2HEST score predicts clinical outcomes in heart failure with preserved ejection fraction: a secondary analysis of the TOPCAT trial
Spironolactone Metabolites in TOPCAT — New Insights into Regional Variation | NEJM
Assessing the Eligibility Criteria in Phase III Randomized Controlled Trials of Drug Therapy in Heart Failure With Preserved Ejection Fraction: The Critical Play-Off Between a “Pure” Patient Phenotype and the Generalizability of
Pharmacoepidemiology | Free Full-Text | Spironolactone Utilization among Patients with Reduced and Preserved Ejection Fraction Heart Failure
Targeting efficacy of spironolactone in patients with heart failure with preserved ejection fraction: the TOPCAT study - Zhou - ESC Heart Failure - Wiley Online Library
Heart failure with preserved ejection fraction: present status and future directions | Experimental & Molecular Medicine
Spironolactone for Heart Failure with Preserved Ejection Fraction | NEJM
Abstract 278: Trends in Prescribing Patterns for Patients Hospitalized With Heart Failure With Preserved Ejection Fraction Before and After Clinical Trial Presentation | Circulation: Cardiovascular Quality and Outcomes
Prognostic Value of Time in Blood Pressure Target Range Among Patients With Heart Failure | JACC: Heart Failure
Spectrum of epidemiological and clinical findings in patients with heart failure with preserved ejection fraction stratified by study design: a systematic review - Vaduganathan - 2016 - European Journal of Heart Failure - Wiley Online Library
Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) Protocols
Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction: The TOPCAT Trial - ScienceDirect
Clinical information from repeated blood pressure measurements in the management of heart failure with preserved ejection fraction | Hypertension Research
Targeting efficacy of spironolactone in patients with heart failure with preserved ejection fraction: the TOPCAT study - Zhou - ESC Heart Failure - Wiley Online Library
Regional Variation in Patients and Outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) Trial | Circulation
Heart failure (HF) hospitalisation across 6 major phase 3 trials of... | Download Scientific Diagram
Towards precision medicine in heart failure | Nature Reviews Cardiology
Detection and Management of Geographic Disparities in the TOPCAT Trial: Lessons Learned and Derivative Recommendations - ScienceDirect
Under-Enrollment of Obese Heart Failure with Preserved Ejection Fraction Patients in Major HFpEF Clinical Trials - Journal of Cardiac Failure
Baseline Characteristics of Patients With HF With Mildly Reduced and Preserved Ejection Fraction: DELIVER Trial | JACC: Heart Failure
Frontiers | The Prescription Characteristics, Efficacy and Safety of Spironolactone in Real-World Patients With Acute Heart Failure Syndrome: A Prospective Nationwide Cohort Study
